Search - tctmd.com

Displaying 161 - 180 of 266

Sort: Relevancy | Date

Presentation TVT 2014

SAPIEN 3 Sizing Considerations: The Concept of True Sizing and Balloon-Volume Reduction

Presenter: John G. Webb

June 07, 2014

Presentation TVT 2014

CT Valve Sizing Algorithms for the CoreValve Self-Expanding Valve: Lessons from the US CoreValve Experience

Presenter: Jeffrey J. Popma

June 07, 2014

Presentation TVT 2014

CT Valve Sizing Algorithms for the SAPIEN Balloon-Expandable Valve: Methodology and Guidelines

Presenter: Jonathon A. Leipsic

June 07, 2014

Presentation TVT 2014

The Concept and Application of Balloon Sizing to Guide Valve Selection

Presenter: Helene Eltchaninoff

June 07, 2014

Presentation TVT 2014

The Concept and Application of Cover Index to Guide Valve Sizing

Presenter: Susheel Kodali

June 07, 2014

Presentation TVT 2014

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Michael J. Mack

June 07, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

News Industry News

Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve

May 20, 2014

News Industry News

CardiAQ™ Valve Technologies reports Successful

May 20, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

L.A. McKeown

March 31, 2014

News Conference News ACC 2014

Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted

Yael L. Maxwell

March 30, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Daily News

La Regurgitación Aórtica se Confirma como un Potente Predictor de la Mortalidad tras TAVR

L.A. McKeown

March 05, 2014

Advertisement

SAPIEN 3 Sizing Considerations: The Concept of True Sizing and Balloon-Volume Reduction

CT Valve Sizing Algorithms for the CoreValve Self-Expanding Valve: Lessons from the US CoreValve Experience

CT Valve Sizing Algorithms for the SAPIEN Balloon-Expandable Valve: Methodology and Guidelines

The Concept and Application of Balloon Sizing to Guide Valve Selection

The Concept and Application of Cover Index to Guide Valve Sizing

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve

CardiAQ™ Valve Technologies reports Successful

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks

Melody Valve Post-Approval Study Demonstrates Results Better than Originally Predicted

TAVR With the CoreValve Device Superior to Surgery at 1 Year

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

La Regurgitación Aórtica se Confirma como un Potente Predictor de la Mortalidad tras TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content